NEPHROS, INC. (NEPH) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 3.34M USD | Liabilities, Current |
| Cash and equivalents | 4.70M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 4.10M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 4.55M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $3.34M | $4.70M | (m) | $4.10M | $4.55M | (m) |
| 2026-03-31 | (m) | $2.53M | $4.02M | (m) | $3.52M | $3.62M | (m) |
| 2025-12-31 | (m) | $2.77M | $5.40M | (m) | $2.41M | $3.23M | (m) |
| 2025-09-30 | (m) | $2.47M | $5.17M | (m) | $2.66M | $2.74M | (m) |
| 2025-06-30 | (m) | $1.77M | $5.07M | (m) | $2.04M | $2.24M | (m) |
| 2025-03-31 | (m) | $1.52M | $4.08M | (m) | $2.68M | $1.95M | (m) |
| 2024-12-31 | (m) | $1.56M | $3.76M | (m) | $1.78M | $2.62M | (m) |
| 2024-09-30 | (m) | $1.06M | $2.46M | (m) | $1.69M | $3.10M | (m) |
| 2024-06-30 | (m) | $1.95M | $3.08M | (m) | $1.88M | $2.80M | (m) |
| 2024-03-31 | (m) | $1.93M | $3.63M | (m) | $1.52M | $2.78M | (m) |
| 2023-12-31 | (m) | $2.11M | $4.31M | (m) | $1.50M | $2.47M | (m) |
| 2023-09-30 | (m) | $1.83M | $4.62M | (m) | $1.44M | $2.27M | (m) |
| 2023-06-30 | (m) | $1.20M | $4.06M | (m) | $1.58M | $2.13M | (m) |
| 2023-03-31 | (m) | $1.42M | $3.84M | (m) | $1.96M | $2.35M | (m) |
| 2022-12-31 | (m) | $1.41M | $3.63M | (m) | $1.29M | $3.15M | (m) |
| 2022-09-30 | (m) | $1.55M | $3.94M | (m) | $1.37M | $3.49M | (m) |
| 2022-06-30 | (m) | $2.11M | $4.18M | (m) | $2.13M | $4.66M | (m) |
| 2022-03-31 | (m) | $1.75M | $5.42M | (m) | $1.29M | $4.68M | (m) |
| 2021-12-31 | (m) | $2.39M | $6.97M | (m) | $1.64M | $4.79M | (m) |
| 2021-09-30 | (m) | $1.82M | $7.35M | (m) | $1.55M | $4.65M | (m) |
| 2021-06-30 | (m) | $2.17M | $8.28M | (m) | $1.38M | $5.09M | (m) |
| 2021-03-31 | (m) | $1.41M | $8.16M | (m) | $1.72M | $4.68M | (m) |
| 2020-12-31 | (m) | $1.32M | $8.25M | (m) | $1.36M | $5.30M | (m) |
| 2020-09-30 | (m) | $2.38M | $5.16M | (m) | $901.00K | $5.38M | (m) |
| 2020-06-30 | (m) | $2.77M | $7.05M | (m) | $870.00K | $4.77M | (m) |
| 2020-03-31 | (m) | $3.11M | $8.96M | (m) | $1.60M | $3.65M | (m) |
| 2019-12-31 | (m) | $2.43M | (m) | (m) | $1.04M | $2.56M | (m) |
| 2019-09-30 | (m) | $3.12M | (m) | (m) | $1.89M | $2.13M | (m) |
| 2019-06-30 | (m) | $3.29M | (m) | (m) | $1.54M | $2.31M | (m) |
| 2019-03-31 | (m) | $3.11M | (m) | (m) | $1.25M | $2.04M | (m) |
| 2018-12-31 | (m) | $2.65M | (m) | (m) | $1.45M | $1.86M | (m) |
| 2018-09-30 | (m) | $1.44M | (m) | (m) | $1.51M | $1.46M | (m) |
| 2018-06-30 | (m) | $1.40M | (m) | (m) | $855.00K | $1.35M | (m) |
| 2018-03-31 | (m) | $1.73M | (m) | (m) | $678.00K | $928.00K | (m) |
| 2017-12-31 | (m) | $1.87M | (m) | (m) | $836.00K | $674.00K | (m) |
| 2017-09-30 | (m) | $1.41M | (m) | (m) | $751.00K | $581.00K | (m) |
| 2017-06-30 | (m) | $923.00K | (m) | (m) | $584.00K | $603.00K | (m) |
| 2017-03-31 | (m) | $780.00K | (m) | (m) | $582.00K | $401.00K | (m) |
| 2016-12-31 | (m) | $895.00K | (m) | (m) | $388.00K | $479.00K | (m) |
| 2016-09-30 | (m) | $684.00K | (m) | (m) | $311.00K | $341.00K | (m) |
| 2016-06-30 | (m) | $1.22M | (m) | (m) | $346.00K | $413.00K | (m) |
| 2016-03-31 | (m) | $1.10M | (m) | (m) | $569.00K | $476.00K | (m) |
| 2015-12-31 | (m) | $959.00K | (m) | (m) | $397.00K | $591.00K | (m) |
| 2015-09-30 | (m) | $1.15M | (m) | (m) | $216.00K | $665.00K | (m) |
| 2015-06-30 | (m) | $1.36M | (m) | (m) | $295.00K | $419.00K | (m) |
| 2015-03-31 | (m) | $1.26M | (m) | (m) | $334.00K | $208.00K | (m) |
| 2014-12-31 | (m) | $1.25M | (m) | (m) | $110.00K | $186.00K | (m) |
| 2014-09-30 | (m) | $3.06M | (m) | (m) | (m) | $108.00K | (m) |
| 2014-06-30 | (m) | $1.68M | (m) | (m) | (m) | $163.00K | (m) |
| 2014-03-31 | (m) | $2.29M | (m) | (m) | (m) | $192.00K | (m) |
| 2013-12-31 | (m) | $3.50M | (m) | (m) | (m) | $162.00K | (m) |
| 2013-09-30 | (m) | $1.95M | (m) | (m) | (m) | $291.00K | (m) |
| 2013-06-30 | (m) | $1.69M | (m) | (m) | (m) | $147.00K | (m) |
| 2013-03-31 | (m) | $3.90M | (m) | (m) | (m) | $189.00K | (m) |
| 2012-12-31 | (m) | $3.42M | (m) | (m) | (m) | $312.00K | (m) |
| 2012-09-30 | (m) | $2.75M | (m) | (m) | (m) | $293.00K | (m) |
| 2012-06-30 | (m) | $2.44M | (m) | (m) | (m) | $268.00K | (m) |
| 2012-03-31 | (m) | $1.34M | (m) | (m) | (m) | $240.00K | (m) |
| 2011-12-31 | (m) | $2.57M | (m) | (m) | (m) | $247.00K | (m) |
| 2011-09-30 | (m) | $1.03M | (m) | (m) | (m) | $396.00K | (m) |
| 2011-06-30 | (m) | $566.00K | (m) | (m) | (m) | $334.00K | (m) |
| 2010-12-31 | (m) | $1.46M | (m) | (m) | (m) | $726.00K | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |